AstraZeneca is one of the largest pharmaceutical companies in the world and is the 2nd largest research-based pharmaceutical company in Canada. Our unique combination of curiosity and a fundamental commitment to patient health are the key drivers of research and development. Looking beyond the obvious and solving problems innovatively enables our scientists and the researchers we support to discover new and better treatments for a wide array of medical conditions and diseases. In Canada, we invest approximately $100 million annually in research and development initiatives. Most of our 1,050 Canadian employees work at our high-tech headquarters in Mississauga, Ontario, while over 120 scientists work at our world-class basic pain research centre in Montréal, Québec. AstraZeneca Research & Development Montréal (AZRDM) is a leader in pain control research, focusing primarily on the mechanisms involved in inflammatory and neuropathic pain, the two most common types of chronic pain. Our innovative and extensive product portfolio focuses on six areas of medicine: Cancer, Cardiovascular disease, Infection, Gastrointestinal disease, Neurological disorders, Respiratory and inflammatory conditions.
Marion McCourt, President and Chief Executive Officer
Address:
1004 Middlegate Road
Mississauga, ON L4Y 1M4
Canada
Telephone number:
905-566-7323
AstraZeneca Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
Name | From | To |
---|---|---|
AstraZeneca Canada Inc. | 2008-07-31 | current |
Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
---|---|---|
Kiersten Combs | 2021-09-01 | Current |
Jane Chung | 2019-11-01 | 2021-09-01 |
Daniel Smedley | 2019-08-01 | 2019-11-01 |
Jamie Freedman | 2017-11-28 | 2019-08-01 |
Ed Dybka | 2015-01-02 | 2017-11-28 |
Elaine Campbell | 2012-01-09 | 2015-01-02 |
Marion McCourt | 2010-04-12 | 2012-01-09 |
Mark Jones | 2007-03-08 | 2010-04-12 |
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Position | Period Held | Last Date Designated Public Office Held |
---|---|---|
Executive Assistant and Special Assistant for Parliamentary Affairs & Communications
House of Commons, Belinda Stronach, M.P. |
2004 to 2005 | Not a designated office |
Parliamentary Assistant
House of Commons, Grant McNally, M.P. |
1999 to 2004 | Not a designated office |
Researcher
Office of the Leader of the Opposition, Preston Manning, M.P. |
1997 to 1999 | Not a designated office |